INOGENIX AI-BASED BIOTECH Trademark

Trademark Overview


On Tuesday, November 17, 2020, a trademark application was filed for INOGENIX AI-BASED BIOTECH with the United States Patent and Trademark Office. The USPTO has given the INOGENIX AI-BASED BIOTECH trademark a serial number of 90323741. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 2, 2024. This trademark is owned by INOGENIX Co., Ltd.. The INOGENIX AI-BASED BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical purposes; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for treating diseases of the metabolic system, cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, digestive disorders and dermatological conditions; veterinary preparations for treating pets for treating diseases of the metabolic system, cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, digestive disorders and dermatological conditions
inogenix ai-based biotech

General Information


Serial Number90323741
Word MarkINOGENIX AI-BASED BIOTECH
Filing DateTuesday, November 17, 2020
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements


Description of MarkThe mark consists of the wording "INOGENIX" where the letters "INO" are in gray and letters "GENIX" are in blue. Below the wording are the words "AI-based BioTech" in gray in smaller font. Above the wording is a design consisting of a doughnut shape connected to a tear drop shape all in blue, and an independent disc shape shaded in blue above and to the right of the aforementioned shape. White represents the background and is not a feature of the mark.
Goods and ServicesDiagnostic preparations for medical purposes; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for treating diseases of the metabolic system, cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, digestive disorders and dermatological conditions; veterinary preparations for treating pets for treating diseases of the metabolic system, cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, digestive disorders and dermatological conditions
Indication of Colors claimedThe color(s) gray and blue is/are claimed as a feature of the mark.
NOT AVAILABLE"AI-BASED BIOTECH"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINOGENIX Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChuncheon, Gangwon-do 24232
KR

Party NameINOGENIX Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChuncheon, Gangwon-do 24232
KR

Trademark Events


Event DateEvent Description
Friday, November 20, 2020NEW APPLICATION ENTERED
Saturday, January 16, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2021ASSIGNED TO EXAMINER
Thursday, May 6, 2021NON-FINAL ACTION WRITTEN
Thursday, May 6, 2021NON-FINAL ACTION E-MAILED
Thursday, May 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 2, 2021LETTER OF SUSPENSION E-MAILED
Thursday, December 2, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 27, 2022SUSPENSION LETTER WRITTEN
Monday, March 20, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, April 26, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 24, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, October 24, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, December 26, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2024ASSIGNED TO LIE
Wednesday, May 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023ASSIGNED TO EXAMINER
Thursday, December 2, 2021SUSPENSION LETTER WRITTEN
Wednesday, June 22, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, July 27, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, July 27, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED